| Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities JLS Au, BZ Yeung, MG Wientjes, Z Lu, MG Wientjes Advanced drug delivery reviews 97, 280-301, 2016 | 155 | 2016 |
| Multiscale tumor spatiokinetic model for intraperitoneal therapy JLS Au, P Guo, Y Gao, Z Lu, MG Wientjes, M Tsai, MG Wientjes The AAPS journal 16, 424-439, 2014 | 36 | 2014 |
| Predicting diffusive transport of cationic liposomes in 3-dimensional tumor spheroids MG Wientjes, BZ Yeung, Z Lu, MG Wientjes, JLS Au Journal of Controlled Release 192, 10-18, 2014 | 27 | 2014 |
| Considerations for the Forced Expiratory Volume in 1 Second‐Based Comparative Clinical Endpoint Bioequivalence Studies for Orally Inhaled Drug Products J Lee, K Feng, DS Conti, R Walenga, M Wientjes, H Wang, B Newman, ... Clinical Pharmacology & Therapeutics 112 (5), 982-989, 2022 | 4 | 2022 |
| Quantitative Pharmacology of Intercellular Drug Shuttle by Exosomes J Wang, M Cui, BZ Yeung, Z Lu, MG Wientjes, S Woo, JLS Au The FASEB Journal 31, 829.5-829.5, 2017 | 1 | 2017 |
| Surgical management of peritoneal metastasis: Opportunities for pharmaceutical research MG Wientjes, Z Lu, CHF Chan, K Turaga, JLS Au Journal of Controlled Release 361, 717-726, 2023 | | 2023 |
| Considerations for the Forced Expiratory Volume in 1 Second (FEV1 )-Based Comparative Clinical Endpoint Bioequivalence Studies for Orally Inhaled Drug Products. J Lee, K Feng, DS Conti, R Walenga, M Wientjes, H Wang, B Newman, ... Clinical Pharmacology and Therapeutics, 2022 | | 2022 |
| Predictive models of diffusive nanoparticle transport in 3D tumor spheroids M Li, M Wientjes, B Yeung, MG Wientjes, JLS Au Cancer Research 74 (19_Supplement), 5422-5422, 2014 | | 2014 |
